Clinical Trials Directory

Trials / Completed

CompletedNCT00436475

Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Tufts Medical Center · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The purpose of the randomized trial is to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for type 2 diabetes.

Detailed description

There is animal and human observational evidence to suggest that vitamin D and calcium are important in modifying t2DM risk but there are critical gaps in our knowledge about the clinical magnitude of the association with t2DM and potential mechanisms in humans. We are conducting a randomized trial to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for t2DM. We anticipate that the research proposed in this application is significant because it will provide the basis for defining feasible nutritional interventions that promotes prevention of t2DM. Based on the results of the proposed studies and future work in this area, vitamin D and calcium supplementation can assume an important role in the treatment of t2DM and in the prevention of the disease in the 41 million Americans who are at risk of developing t2DM.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3 2,000 IU orally once dailyVitamin D3 2,000 IU orally once daily
DRUGCalcium Carbonate 400 mg orally twice dailyCalcium Carbonate 400 mg orally twice daily
DRUGVitamin D3-PlaceboVitamin D3-Placebo
DRUGCalcium-PlaceboCalcium-Placebo

Timeline

Start date
2007-09-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2007-02-19
Last updated
2019-07-30
Results posted
2019-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00436475. Inclusion in this directory is not an endorsement.